Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$305M |
| 2 |
Tesla
TSLA
|
+$304M |
| 3 |
ExxonMobil
XOM
|
+$277M |
| 4 |
Warner Bros
WBD
|
+$263M |
| 5 |
Linde
LIN
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
CERN
Cerner Corp
CERN
|
+$371M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$310M |
| 4 |
Philip Morris
PM
|
+$254M |
| 5 |
S&P Global
SPGI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.19% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 12.06% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Invesco DB US Dollar Index Bullish Fund
UUP
$413M
| $1.61M | ﹤0.01% |
+57,724
| New | +$1.58M |
|
|
MORF
2952
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.61M | ﹤0.01% |
74,204
+4,824
| +7% | +$135K |
|
2953
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.34B
| $1.59M | ﹤0.01% |
33,299
+17,317
| +108% | +$929K |
|
2954
indie Semiconductor
INDI
$995M
| $1.59M | ﹤0.01% |
279,894
+255,476
| +1,046% | +$1.76M |
|
|
SCHR
2955
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $1.59M | ﹤0.01% |
61,804
+17,894
| +41% | +$463K |
|
2956
NACCO Industries
NC
$322M
| $1.59M | ﹤0.01% |
41,957
+11,495
| +38% | +$548K |
|
|
CONN
2957
DELISTED
Conn's Inc.
CONN
| $1.59M | ﹤0.01% |
198,263
-34,356
| -15% | -$451K |
|
|
EBTC
2958
DELISTED
Enterprise Bancorp
EBTC
| $1.59M | ﹤0.01% |
49,362
-3,295
| -6% | -$113K |
|
|
MRSN
2959
DELISTED
Mersana Therapeutics
MRSN
| $1.59M | ﹤0.01% |
13,748
+2,424
| +21% | +$228K |
|
2960
Escalade
ESCA
$276M
| $1.58M | ﹤0.01% |
121,988
-22,715
| -16% | -$297K |
|
|
BTRS
2961
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $1.58M | ﹤0.01% |
318,064
-1,669
| -0.5% | -$9.6K |
|
|
VERV
2962
DELISTED
Verve Therapeutics
VERV
| $1.58M | ﹤0.01% |
103,556
-12,231
| -11% | -$189K |
|
2963
Alerus Financial
ALRS
$838M
| $1.58M | ﹤0.01% |
66,413
-6,058
| -8% | -$154K |
|
2964
Weyco Group
WEYS
$432M
| $1.58M | ﹤0.01% |
64,551
+14,743
| +30% | +$398K |
|
2965
Lifestance Health
LFST
$4.75B
| $1.58M | ﹤0.01% |
283,590
+56,417
| +25% | +$432K |
|
2966
Future Fuel
FF
$245M
| $1.57M | ﹤0.01% |
215,706
-12,098
| -5% | -$102K |
|
2967
AnaptysBio
ANAB
$1.73B
| $1.57M | ﹤0.01% |
77,242
-7,473
| -9% | -$166K |
|
2968
Castle Biosciences
CSTL
$905M
| $1.56M | ﹤0.01% |
71,238
-30,648
| -30% | -$712K |
|
2969
WisdomTree International MidCap Dividend Fund
DIM
$169M
| $1.56M | ﹤0.01% |
28,232
+10,462
| +59% | +$633K |
|
2970
AvePoint
AVPT
$2.85B
| $1.56M | ﹤0.01% |
359,563
+325,388
| +952% | +$1.65M |
|
|
AMRS
2971
DELISTED
Amyris Inc.
AMRS
| $1.56M | ﹤0.01% |
841,602
+121,787
| +17% | +$358K |
|
|
YMAB
2972
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.55M | ﹤0.01% |
102,657
-1,478
| -1% | -$17.2K |
|
2973
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.87B
| $1.55M | ﹤0.01% |
65,266
-940
| -1% | -$24K |
|
2974
MVB Financial
MVBF
$398M
| $1.55M | ﹤0.01% |
49,897
-4,291
| -8% | -$162K |
|
2975
Utah Medical Products
UTMD
$226M
| $1.55M | ﹤0.01% |
18,074
-1,874
| -9% | -$160K |
|
Similar funds
Bank of New York Mellon's Q2 2022 Portfolio in Review
As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
- Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
- Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
- Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
- Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
- Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.